Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

GPCR Roundtable Participants

By Drug Discovery Trends Editor | February 2, 2009

Web Exclusive

Meet the scientists of Drug Discovery & Development magazine’s GPCR Roundtable.

Suresh PodaSuresh Poda (PhD, biochemistry), is a senior scientist at the HTS Center for Lundbeck in Paramus, N.J. The company’s research focuses on CNS disorders. While the primary targets are GPCRs—monoimmuno receptors and other GPCRs that are involved in neurotransmitter pathways—the company also studies ion channel and enzyme targets.

 

Charles A. LunnCharles A. Lunn (PhD, biochemistry), is a research fellow in New Lead Discovery at Schering-Plough Research Institute in Kenilworth, N.J. His group develops HTS assays. Targets include immunology and cardiovascular disease. Most of the GPCR targets investigated in recent years have utilized cell-based assays, looking at second messengers, as well as more primary readouts.

 

Richard EglenRichard Eglen (PhD, pharmacology), is president of Bio-discovery at PerkinElmer, Waltham, Mass. He has worked in drug discovery at GPCRs, as well as the development of technologies to screen compounds at GPCRs for central nervous system, cardiovascular, and metabolic disorders. His research has focused on muscarinic, serotonergic, and opioid receptors.


Filed Under: Drug Discovery

 

Related Articles Read More >

Sanders, King target DTC pharma ads but the industry worries more about threats to its $2B R&D model
Zoliflodacin wins FDA nod for treatment of gonorrhea
FDA approved ENFLONSIA for the prevention of RSV in Infants
First clinical study results of Dupixent for atopic dermatitis in patients with darker skin tones 
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE